10-Q: Q2 2024 Earnings Report
Form 144 | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 446.84K in Common Stocks
SEC FILLINGS DISCLOSED/ May 17, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTIC
Form 144 | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 194.71K in Common Stocks
SEC FILLINGS DISCLOSED/ May 16, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTIC
Form 144 | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 505.15K in Common Stocks
SEC FILLINGS DISCLOSED/ May 15, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTIC
Form 144(Amend) | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 290.83K in Common Stocks
SEC FILLINGS DISCLOSED/ May 15, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTIC
Form 144 | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 1.2 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 14, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTIC
Form 144 | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 434.5K in Common Stocks
SEC FILLINGS DISCLOSED/ May 13, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTIC
Form 144 | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 830.45K in Common Stocks
SEC FILLINGS DISCLOSED/ May 9, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTICA
10-Q: Q1 2024 Earnings Report
Ligand to Report First Quarter 2024 Financial Results on May 7, 2024
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI
No Data
No Data